store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the HCV NS5B RNA-dependent RNA polymerase. It inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 (IC50 < 28 nM).
产品描述 | Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the HCV NS5B RNA-dependent RNA polymerase. It inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 (IC50 < 28 nM). |
靶点活性 | NS5B protein:< 28 nM |
体外活性 | Beclabuvir shows additive or synergistic antiviral activity with pegIFN/RBV and in 2- or 3-drug combinations with a range of DAAs, such as HCV NS5A inhibitors, NS3 protease inhibitors and/or nucleoside NS5B inhibitors [2]. |
体内活性 | The combination of Beclabuvir with daclatasvir and asunaprevir achieves very high rates of viral eradication (about 90%) in patients infected with HCV genotype 1, which is the most common genotype worldwide [1]. |
别名 | BMS-791325 |
分子量 | 659.84 |
分子式 | C36H45N5O5S |
CAS No. | 958002-33-0 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (45.47 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.5155 mL | 7.5776 mL | 15.1552 mL | 37.888 mL |
5 mM | 0.3031 mL | 1.5155 mL | 3.031 mL | 7.5776 mL | |
10 mM | 0.1516 mL | 0.7578 mL | 1.5155 mL | 3.7888 mL | |
20 mM | 0.0758 mL | 0.3789 mL | 0.7578 mL | 1.8944 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Beclabuvir 958002-33-0 Others BMS791325 BMS-791325 BMS 791325 Inhibitor inhibitor inhibit